Mizuho Lowers Acadia Healthcare (NASDAQ:ACHC) Price Target to $37.00

Acadia Healthcare (NASDAQ:ACHC) had its target price cut by investment analysts at Mizuho from $48.00 to $37.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Mizuho’s price target would suggest a potential upside of 24.75% from the company’s previous close.

Other equities research analysts have also recently issued research reports about the stock. Barclays downgraded Acadia Healthcare from an “overweight” rating to an “equal weight” rating and dropped their target price for the stock from $43.00 to $35.00 in a research report on Friday, February 28th. KeyCorp dropped their price objective on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a report on Monday, March 3rd. TD Cowen reduced their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Finally, Royal Bank of Canada decreased their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. According to MarketBeat, Acadia Healthcare presently has an average rating of “Hold” and an average price target of $52.19.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $29.66 on Tuesday. The firm has a market cap of $2.76 billion, a P/E ratio of 9.72, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The company’s 50 day moving average is $37.65 and its 200-day moving average is $45.71. Acadia Healthcare has a 12-month low of $27.61 and a 12-month high of $82.41.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Lindbrook Capital LLC lifted its stake in Acadia Healthcare by 1,342.0% during the fourth quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock worth $29,000 after purchasing an additional 671 shares during the last quarter. Blue Trust Inc. lifted its position in Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after buying an additional 345 shares during the last quarter. Nisa Investment Advisors LLC boosted its stake in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after buying an additional 301 shares in the last quarter. Signaturefd LLC lifted its holdings in shares of Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock worth $48,000 after acquiring an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp boosted its stake in shares of Acadia Healthcare by 56.0% in the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after purchasing an additional 454 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.